{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:41:21Z","timestamp":1777581681048,"version":"3.51.4"},"reference-count":25,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Background: The purpose of this study is to examine the combination of the mechanical effects of penile therapy with vacuum erection devices (VEDs) plus PDE5i, which improve clinical outcomes after extracorporeal shockwave therapy (ESWT) in men affected by erectile dysfunction (ED) associated with Peyronie\u2019s disease (PD). Methods: A total of 153 medical records of patients affected by PD in stable stage with ED and treated with ESWT were divided into two groups. Group A (GA) included 72 men treated with ESWT, mechanical stretching with VEDs and PDE5\u00ec (Tadalafil 5 mg), and Group B (GB) included 81 men who received only ESWT plus Tadalafil 5 mg with the same protocol of GA. The patients in both groups were assessed at baseline and follow-up for erectile function, painful erections, penile plaque size, and penile curvature. The results were evaluated at baseline and 3, 6, and 12 months after the treatments. Results: Three months after the treatment, GA patients had a reduction in penile curvature degree from a mean \u00b1 SD of 33.91 \u00b1 8.34\u00b0 at baseline to a mean \u00b1 SD of 19.46 \u00b1 7.15\u00b0 after 12 months, whereas pain in an erection or during intercourse was resolved completely in 88.9% of the patients. The mean \u00b1 SD IIEF-15 score of patients affected by severe\/moderate ED further improved significantly in the GA group (p &lt; 0.001) after 3, 6, and 12 months of treatment. There were no permanent adverse sequelae after treatments. Conclusions: The regular use of a VED plus Tadalafil in patients who had undergone ESWT significantly provided more benefit in patients with PD in terms of penile deformity, pain, and erectile function.<\/jats:p>","DOI":"10.3390\/life14091162","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T06:39:16Z","timestamp":1726209556000},"page":"1162","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vacuum Erection Device Plus Once-Daily Tadalafil Improve Clinical Outcomes after Extracorporeal Shock Wave Therapy in Men Affected by Erectile Dysfunction Associated with Peyronie\u2019s Disease"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8471-9965","authenticated-orcid":false,"given":"Lucio","family":"Dell\u2019Atti","sequence":"first","affiliation":[{"name":"Department of Urology, University-Hospital of Marche, 60126 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoria","family":"Slyusar","sequence":"additional","affiliation":[{"name":"Pain Therapy Center, Division of Anesthesia and Intensive Care, University-Hospital of Marche, 60126 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Ronchi","sequence":"additional","affiliation":[{"name":"Department of Urology, University-Hospital of Marche, 60126 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1505-2889","authenticated-orcid":false,"given":"Chiara","family":"Cambise","sequence":"additional","affiliation":[{"name":"Department of Emergency, University-Hospital Gemelli IRCSS, 00168 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.sxmr.2019.06.004","article-title":"The Etiology of Peyronie\u2019s Disease: Pathogenesis and Genetic Contributions","volume":"8","author":"Sharma","year":"2020","journal-title":"Sex. Med. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/iju.14230","article-title":"Peyronie\u2019s disease: Contemporary evaluation and management","volume":"27","author":"Ziegelmann","year":"2020","journal-title":"Int. J. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ucl.2021.07.013","article-title":"Technological Advancements for Treating Erectile Dysfunction and Peyronie\u2019s Disease","volume":"49","author":"Campbell","year":"2022","journal-title":"Urol. Clin. N. Am."},{"key":"ref_4","first-page":"CD012206","article-title":"Non-surgical therapies for Peyronie\u2019s disease","volume":"7","author":"Rosenberg","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.4103\/aja.aja_50_19;","article-title":"Adding a vacuum erection device to regular use of Tadalafil improves penile rehabilitation after posterior urethroplasty","volume":"21","author":"Zhang","year":"2019","journal-title":"Asian J. Androl."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3390\/clinpract13050112","article-title":"The Use of Vacuum Devices as Adjuvant Therapy before and after Penile Curvature Surgery in Patients Affected by La Peyronie\u2019s Disease: Results from a Comparative Study","volume":"13","author":"Cai","year":"2023","journal-title":"Clin. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.21037\/tau.2016.11.01","article-title":"Understanding the cellular basis and pathophysiology of Peyronie\u2019s disease to optimize treatment for erectile dysfunction","volume":"6","author":"Campbel","year":"2017","journal-title":"Transl. Androl. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4103\/0974-7796.152048","article-title":"Tadalafil once daily and intralesional verapamil injection: A new therapeutic direction in Peyronie\u2019s disease","volume":"7","year":"2015","journal-title":"Urol. Ann."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1464-410X.2007.07223.x","article-title":"Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection","volume":"101","author":"Kovanecz","year":"2008","journal-title":"BJU Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/andr.13224","article-title":"Peyronie\u2019s disease development and management in diabetic men","volume":"11","author":"Gianazza","year":"2023","journal-title":"Andrology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s40618-023-02015-5","article-title":"The Italian Society of Andrology and Sexual Medicine (SIAMS), along with ten other Italian Scientific Societies, guidelines on the diagnosis and management of erectile dysfunction","volume":"46","author":"Corona","year":"2023","journal-title":"J. Endocrinol. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s00345-023-04533-6","article-title":"Low-intensity laser diode plus extracorporeal shock wave therapy: A new treatment strategy in the management of Peyronie\u2019s disease","volume":"41","author":"Ronchi","year":"2023","journal-title":"World J. Urol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/01.ju.0000108060.30363.8d","article-title":"Extracorporeal shock wave therapy for Peyronie\u2019s disease: Exploratory meta-analysis of clinical trials","volume":"171","author":"Hauck","year":"2004","journal-title":"J. Urol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1111\/jsm.12275","article-title":"Extracorporeal shock wave therapy in Peyronie\u2019s disease: Results of a placebo-controlled, prospective, randomized, single-blind study","volume":"10","author":"Hatzichristodoulou","year":"2013","journal-title":"J. Sex. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4103\/0974-7796.192100","article-title":"Role of extracorporeal shock wave therapy in management of Peyronie\u2019s disease: A preliminary report","volume":"8","author":"Shimpi","year":"2016","journal-title":"Urol. Ann."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.juro.2011.12.117","article-title":"Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study","volume":"187","author":"Vardi","year":"2012","journal-title":"J. Urol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1743-6109.2011.02498.x","article-title":"Low-intensity extracorporeal shock wave therapy\u2014A novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy","volume":"9","author":"Gruenwald","year":"2012","journal-title":"J. Sex. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.eururo.2009.05.012","article-title":"A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie\u2019s disease","volume":"56","author":"Palmieri","year":"2009","journal-title":"Eur. Urol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1464-410X.2010.09365.x","article-title":"The role of vacuum pump therapy to mechanically straighten the penis in Peyronie\u2019s disease","volume":"106","author":"Garaffa","year":"2010","journal-title":"BJU Int."},{"key":"ref_20","first-page":"715","article-title":"A Randomized, Single-Blinded Clinical Trial Evaluating the Effect of Extracorporeal Shockwave Treatment (ESWT) as Add-On Therapy to Vacuum Erectile Device on Peyronie\u2019s Disease","volume":"13","author":"Mortensen","year":"2021","journal-title":"Res. Rep. Urol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Chirca, N., Streinu-Cercel, A., Stefan, M., Aurelian, J., and Persu, C. (2023). A novel risk calculator to predict erectile dysfunction in HIV-positive men. J. Pers. Med., 13.","DOI":"10.3390\/jpm13040679"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1569-9056(17)30442-6","article-title":"Daily tadalafil therapy: A new treatment option for Peyronie\u2019s disease?","volume":"16","author":"Park","year":"2017","journal-title":"Eur. Urol. Suppl."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s00120-009-2089-y","article-title":"Chronic PDE-5 inhibition in patients with erectile dysfunction: New treatment approach using once daily 2009","volume":"48","author":"Porst","year":"2009","journal-title":"Urol. A"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2605.2011.01226.x","article-title":"Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie\u2019s disease and erectile dysfunction: Results from a prospective randomized trial","volume":"35","author":"Palmieri","year":"2012","journal-title":"Int. J. Androl."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s00345-024-04792-x","article-title":"Long-term experiences with high-energy shock wave therapy in the management chronic phase Peyronie\u2019s disease using two different electromagnetic lithotripters","volume":"42","author":"Rassweiler","year":"2024","journal-title":"World J. Urol."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/14\/9\/1162\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:55:37Z","timestamp":1760111737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/14\/9\/1162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["life14091162"],"URL":"https:\/\/doi.org\/10.3390\/life14091162","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]}}}